» Articles » PMID: 20147470

Nutritional Aspects of HIV-associated Wasting in Sub-Saharan Africa

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2010 Feb 12
PMID 20147470
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The twin global epidemics of HIV infection and food scarcity disproportionately affect sub-Saharan Africa, and a significant proportion of patients who require antiretroviral therapy (ART) are malnourished because of a combination of HIV-associated wasting and inadequate nutrient intake. Protein-calorie malnutrition, the most common form of adult malnutrition in the region, is associated with significant morbidity and compounds the immunosuppressive effects of HIV. A low body mass index (BMI), a sign of advanced malnutrition, is an independent predictor of early mortality (<6 mo) after ART initiation in several analyses, and recent studies show an association between early weight gain when receiving ART and improved treatment outcomes. The cause of the observed increase in mortality is uncertain, but it is likely due in part to malnutrition-induced immune system dysfunction, a higher burden of opportunistic infections, and metabolic derangements. In this article, we describe the epidemiology of HIV infection and malnutrition in sub-Saharan Africa, potential causes of increased mortality after ART initiation among patients with a low BMI, recent studies on post-ART weight gain and treatment outcome, and trials of macronutrient supplementation from the region. We close by highlighting priority areas for future research.

Citing Articles

The consequences of climate change and male reproductive health: A review of the possible impact and mechanisms.

Akhigbe R, Oyedokun P, Akhigbe T, Hamed M, Fidelis F, Omole A Biochem Biophys Rep. 2024; 41:101889.

PMID: 39717849 PMC: 11664087. DOI: 10.1016/j.bbrep.2024.101889.


Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study.

Madlala H, Myer L, Jao J, Geffen H, Matjila M, Fisher A J Int AIDS Soc. 2024; 27(6):e26313.

PMID: 38926935 PMC: 11208166. DOI: 10.1002/jia2.26313.


Dietary regimens appear to possess significant effects on the development of combined antiretroviral therapy (cART)-associated metabolic syndrome.

Chege B, Mwangi P, Githinji C, Bukachi F PLoS One. 2024; 19(2):e0298752.

PMID: 38416754 PMC: 10901320. DOI: 10.1371/journal.pone.0298752.


Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease.

Bares S, Wu X, Tassiopoulos K, Lake J, Koletar S, Kalayjian R Clin Infect Dis. 2023; 78(2):395-401.

PMID: 37698083 PMC: 10874261. DOI: 10.1093/cid/ciad545.


A Systematic Review on Cardiometabolic Risks and Perinatal Outcomes among Pregnant Women Living with HIV in the Era of Antiretroviral Therapy.

Modjadji P, Mokgalaboni K, Nonterah E, Lebelo S, Mchiza Z, Madiba S Viruses. 2023; 15(7).

PMID: 37515129 PMC: 10385451. DOI: 10.3390/v15071441.


References
1.
SCHNITKER M, MATTMAN P, BLISS T . A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med. 1951; 35(1):69-96. DOI: 10.7326/0003-4819-35-1-69. View

2.
Ott M, Lembcke B, Fischer H, Jager R, Polat H, Geier H . Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr. 1993; 57(1):15-9. DOI: 10.1093/ajcn/57.1.15. View

3.
Melchior J, Salmon D, Rigaud D, Leport C, Bouvet E, Detruchis P . Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr. 1991; 53(2):437-41. DOI: 10.1093/ajcn/53.2.437. View

4.
. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Suppl. 1987; 36(1):1S-15S. View

5.
Shevitz A, Knox T, Spiegelman D, Roubenoff R, Gorbach S, Skolnik P . Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. AIDS. 1999; 13(11):1351-7. DOI: 10.1097/00002030-199907300-00012. View